THE LATEST FROM US

News archive

EPID Research presented two posters in ESC 2016

1.9.2016 – Ville Kytö presented two posters of a study conducted by EPID Research in ESC Congress 2016, 27-31 August, 2016: – Gender differences in oral antiplatelet treatment use – results from a nationwide cohort study of acute coronary syndrome patients in Finland – Post...

EPID Research presented four posters in 32nd ICPE

29.8.2016 – EPID Research presented four posters in ICPE 32nd International Conference, 25-28 August, 2016: – Contraindicated and off-label drug use in pediatric outpatients in the Nordic countries – Spotlight poster – COPD Patients Initiating Roflumilast in Sweden, German...

Cardiac mortality and use of progestin for menopause study

12.5.2016 – Our new article on cardiac mortality and use of progestin for menopause has been published. Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies. Published in Journal of Endocrinology & Metabolism, doi: 10.1210/jc.2015-4149 ...

New article on basal insulins

31.3.2016 – Our new article on mortality and use of certain basal insulins has been published. All-cause and cause-specific mortality among users of basal insulins NPH, detemir and glargine. Published in PLoS One 2016, doi:10.1371/journal.pone.0151910 –Article...

Melanoma treatment and RWD

23.11.2015 – Melinda Manley Daumont presented a poster of a study conducted by EPID Research “Comparative effectiveness research of treatments for advanced melanoma in Europe using existing real-world data sources: A feasibility assessment” in the Society for Melanoma Research 201...

Risk of stroke with warfarin therapy

17.11.2015 – Mika Lehto gave an oral presentation of a study conducted by EPID Research titled “Risk of stroke, bleeding events and mortality is strongly associated with the quality of warfarin therapy. Results from the FinWAF registry with 54,568 patients” in the American Heart ...
Are you interested in learning more about how our RWE solutions can help you in your drug development and surveillance? Our team of experts is eager to discuss your specific needs. To learn more, please contact us at office@epidresearch.com.